Oral Budesonide Suspension (MB-9) ( DrugBank: Budesonide )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
98	好酸球性消化管疾患	1

98. 好酸球性消化管疾患

---

臨床試験数 : 171 /  薬物数 : 184 - (DrugBank : 47) / 標的遺伝子数 : 42 - 標的パスウェイ数 : 141

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01642212 (ClinicalTrials.gov)	July 23, 2012	13/7/2012	OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension	Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11-40 Years of Age)With Eosinophilic Esophagitis: A Phase II, Randomized, Double-Blind, Placebo-Controlled Study With an Open Label Extension	Eosinophilic Esophagitis (EoE)	Drug: Oral Budesonide Suspension (MB-9);Drug: Placebo	Shire	NULL	Completed	11 Years	40 Years	All	93	Phase 2	United States